Peripheral NK cell phenotypic alteration and dysfunctional state post hepatitis B subviral particles stimulation in CHB patients: evading immune surveillance.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 03 05 2024
accepted: 15 08 2024
medline: 27 9 2024
pubmed: 27 9 2024
entrez: 27 9 2024
Statut: epublish

Résumé

The relationship between chronic hepatitis B (CHB) infection and natural killer (NK) cell dysfunction is well-established, but the specific role of HBV viral antigens in driving NK cell impairment in patients with CHB remains unclear. This study investigates the modulatory effects of hepatitis B virus subviral particles (HBVsvp, a representative model for HBsAg) on the phenotypic regulation (activating and inhibitory receptors), cytokine production and cytotoxic potential of peripheral blood mononuclear cell-derived natural killer cells (PBMCs-derived NK cell), which contributes to NK cell dysfunction in CHB infection, potentially serving as an effective HBV immune evasion strategy by the virus. NK cells were isolated from peripheral blood of patients with CHB (n=5) and healthy individuals (n=5), stimulated with HBVsvp. Subsequent flow cytometric characterization involved assessing changes in activating (NKp46 and NKG2D) and inhibitory (CD94) receptors expression, quantifying TNF-α and IFN- γ cytokine secretion, and evaluating the cytotoxic response against HepG2.2.15 cells with subsequent HBVsvp quantification. In CHB patients, These findings suggest that HBVsvp may induce dysfunctional NK cell responses characterized by phenotypic imbalance with subsequent reduction in cytokine and cytotoxic levels, indicating HBVsvp immunosuppressive effect that compromises antiviral defense in CHB patients. These data enhance our understanding of NK cell interactions with HBsAg and highlight the potential for targeting CD94 inhibitory receptors to restore NK cell function as an immunotherapeutic approach. Further clinical research is needed to validate these observations and establish their utility as reliable biomarkers.

Sections du résumé

Background UNASSIGNED
The relationship between chronic hepatitis B (CHB) infection and natural killer (NK) cell dysfunction is well-established, but the specific role of HBV viral antigens in driving NK cell impairment in patients with CHB remains unclear. This study investigates the modulatory effects of hepatitis B virus subviral particles (HBVsvp, a representative model for HBsAg) on the phenotypic regulation (activating and inhibitory receptors), cytokine production and cytotoxic potential of peripheral blood mononuclear cell-derived natural killer cells (PBMCs-derived NK cell), which contributes to NK cell dysfunction in CHB infection, potentially serving as an effective HBV immune evasion strategy by the virus.
Methods UNASSIGNED
NK cells were isolated from peripheral blood of patients with CHB (n=5) and healthy individuals (n=5), stimulated with HBVsvp. Subsequent flow cytometric characterization involved assessing changes in activating (NKp46 and NKG2D) and inhibitory (CD94) receptors expression, quantifying TNF-α and IFN- γ cytokine secretion, and evaluating the cytotoxic response against HepG2.2.15 cells with subsequent HBVsvp quantification.
Results UNASSIGNED
In CHB patients,
Conclusion UNASSIGNED
These findings suggest that HBVsvp may induce dysfunctional NK cell responses characterized by phenotypic imbalance with subsequent reduction in cytokine and cytotoxic levels, indicating HBVsvp immunosuppressive effect that compromises antiviral defense in CHB patients. These data enhance our understanding of NK cell interactions with HBsAg and highlight the potential for targeting CD94 inhibitory receptors to restore NK cell function as an immunotherapeutic approach. Further clinical research is needed to validate these observations and establish their utility as reliable biomarkers.

Identifiants

pubmed: 39328404
doi: 10.3389/fimmu.2024.1427519
pmc: PMC11424423
doi:

Substances chimiques

Cytokines 0
NK Cell Lectin-Like Receptor Subfamily K 0
Hepatitis B Surface Antigens 0
KLRK1 protein, human 0
NK Cell Lectin-Like Receptor Subfamily D 0
Natural Cytotoxicity Triggering Receptor 1 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1427519

Informations de copyright

Copyright © 2024 Selim, Suef, Saied, Abdel-Maksoud, Almutairi, Aufy, Mousa, Mansour and Farag.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Mohamed A Selim (MA)

Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt.

Reda A Suef (RA)

Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt.

Ebrahim Saied (E)

Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt.

Mostafa A Abdel-Maksoud (MA)

Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.

Saeedah Musaed Almutairi (SM)

Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.

Mohammed Aufy (M)

Department of Pharmaceutical Sciences, Division of Pharmacology and Toxicology, University of Vienna, Vienna, Austria.

Adel A Mousa (AA)

Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt.

Mohamed T M Mansour (MTM)

Virology and Immunology Department, National Cancer Institute, Cairo University and Childern's Cancer Hospital, Cairo, Egypt.

Mohamed M S Farag (MMS)

Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Cairo, Egypt.
Biomedical Research Department, Armed Forces College of Medicine (AFCM), Cairo, Egypt.
The Regional Centre for Mycology and Biotechnology, Al-Azhar University, Cairo, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH